Manuel Portero Otin
Grau: Doctor/a
973 702 408
manuel.portero(ELIMINAR)@udl.cat
ResearcherID: http://www.researcherid.com/rid/B-7122-2009
Publicacions
-
Ballester M; Quintanilla R; Ortega FJ; Serrano JCE; Cassanyé A; Rodríguez-Palmero M; Moreno-Muñoz JA; Portero-Otin M; Tibau J
Dietary intake of bioactive ingredients impacts liver and adipose tissue transcriptomes in a porcine model of prepubertal early obesity.
SCIENTIFIC REPORTS 10 5375-5375. .
-
Torres, P; Andres-Benito, P; Fernàndez-Bernal A; Ricart, M; Ayala, V; Pamplona, R; Ferrer, I; Portero-Otin, M
Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy.
BRAIN 143 20-. .
-
Moreno, JA; Diaz-Gomez, J; Fuentes-Font, L; Angulo, E; Gosalvez, LF; Sandmann, G; Portero-Otin, M; Capell, T; Zhu, C; Christou, P; Nogareda, C
Poultry diets containing (keto)carotenoid-enriched maize improve egg yolk color and maintain quality
ANIMAL FEED SCIENCE AND TECHNOLOGY 260 114334-114334. .
-
Torres, P; Cacabelos, D; Pairada, J; Bauer, KC; Boada, J; Fontdevila, L; Rossi, C; Povedano, M; Ferrer, I; Pamplona, R; Finlay, BB; Portero-Otin, M; Ayala, V
Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice.
NEUROTHERAPEUTICS 17 269-281. .
-
Yin, XY; Willinger, CM; Keefe, J; Liu, J; Fernandez-Ortiz, A; Ibáñez B; Peñalvo J; Adourian, A; Chen, G; Corella, D; Pamplona, R; Portero-Otin, M; Jove, M; Courchesne, P; van Duijn, CM; Fuster, V; Ordovas, JM; Demirkan, A; Larson, MG; Levy, D
Lipidomic profiling identifies signatures of metabolic risk.
EBioMedicine 51 102520-102520. .
-
Prieto, I; Alarcon, CR; Garcia-Gomez, R; Berdun, R; Urgel, T; Portero, M; Pamplona, R; Martinez-Ruiz, A; Ruiz-Sanz, JI; Ruiz-Larrea, MB; Jove, M; Cerdan, S; Monsalve, M
Metabolic adaptations in spontaneously immortalized PGC-1a knock-out mouse embryonic fibroblasts increase their oncogenic potential.
Redox Biology 29 101396-101396. .
-
Gubina, N; Naudi, A; Stefanatos, R; Jove, M; Scialo, F; Fernandez-Ayala, DJ; Rantapero, T; Yurkevych, I; Portero-Otin, M; Nykter, M; Lushchak, O; Navas, P; Pamplona, R; Sanz, A
Essential Physiological Differences Characterize Short- and Long-Lived Strains of Drosophila melanogaster
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES 74 1835-1843. .
-
Cassanye, A; Martin-Gari, M; Portero-Otin, M; Serrano, JCE
Adipose Tissue Mitochondrial Factors Profile after Dietary Bioactive Compound Weight Reduction Treatments in a Mice Obesity Model
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 20 -. .
-
Sanchez, E; Lecube, A; Betriu À; Hernandez, C; Lopez-Cano, C; Gutierrez-Carrasquilla, L; Kerkeni, M; Yeramian, A; Purroy, F; Pamplona, R; Farràs C; Fernandez, E; Barbe, F; Simo, R; ILERVAS project; Hernández M; Rius F; Polanco D; de la Torre MS; Torres G; Godoy P; Portero-Otin M; Jové M; Colàs-Compàs L; Benabdelhak I; Miquel E; Ortega M; Valdivielso JM; Bermúdez M; Martínez-Alonso M
Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The MR-1 ILERVAS Project
Diabetes & metabolism 45 595-598. .
-
Casasnovas, C; Ruiz, M; Schlüter A; Naud?, A; Fourcade, S; Veciana, M; Casta?er, S; Albert?, A; Bargall?, N; Johnson, M; Raymond, GV; Fatemi, A; Moser, AB; Villarroya, F; Portero-Ot?n, M; Artuch, R; Pamplona, R; Pujol, A
Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study
NEUROTHERAPEUTICS 16 1167-1182. .
-
Ruiz-Plazas, X; Rodriguez-Gallego, E; Alves, M; Altuna-Coy, A; Lozano-Bartolome, J; Portero-Otin, M; Garcia-Fontgivell, JF; Martinez-Gonzalez, S; Segarra, J; Chacon, MR
Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness
Journal Of Translational Medicine 17 307-307. .
-
Gonzalo, H; Nogueras, L; Gil-Sanchez, A; Hervas, JV; Valcheva, P; Gonzalez-Mingot, C; Martin-Gari, M; Canudes, M; Peralta, S; Solana, MJ; Pamplona, R; Portero-Otin, M; Boada, J; Serrano JCE; Brieva, L
Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients
Frontiers in Neuroscience 13 938-938. .
Projectes
- Natural microbicides from rice against current and emerging infectious diseases
- Humanised mouse models to study ATG4B cryptic exon involvement in ALS pathogenesis and its potential as disease biomarker (Hum4ALS)
- Targeting cryptic exons as biomarkers and ALS therapy
- Desregulacion de TDP-43,eje clave en la ELA: Caracterización de firmas lipidómicas, transcriptómicas y autofágicas en muestras específicas de pacientes para biomarcadores y reposicionamiento
- The role of defects in mitochondria-associated ER membranes (MAM) to Amyotrophic Lateral Sclerosis
- Perspectivas clínicas de la biología de sistemas aplicada al análisis de placas carotídeas humanas: ILER-CAROTID
- Metabolismo lipidico intracelular, procesamiento de ARNm y estrés celular en la encrucijada de la fisiopatología de la esclerosis lateral amiotrófica
- Identification of compounds for inhibition of ACE2 membrane expression
- Reposicionamiento terapéutico dirigido a inhibición de expresión de ACE2 y de proteolisis de trímero S viral
- Determinació de components bioactius derivats de la microbiota mitjançant micromostreig
- Estrés celulares y alteraciones en los lipidomas neuronales, gliales y extracelulares en la fisiopatología de la esclerosis lateral amiotrófica.
- "Imagenoma de l'Envelliment": Estudi observacional poblacional per definir biomarcadors d'imatge RM corporal integral i òmics que s'associen al procés d'envelliment i a factors de risc biopsicosocial en subjectes adults i que defineixen la seva trajectòria vital cap a un envelliment saludable o bé la fragilitat i discapacitat.
